E-learning to Improve Oral Anticoagulant Use in Hospitalized Older People With AF (SIM-AF)
Simulation Training, Anticoagulant Drugs, Elderly
About this trial
This is an interventional other trial for Simulation Training
Eligibility Criteria
Inclusion Criteria:
- subjects 65 years of age or older, with known or newly diagnosed AF, admitted to the Internal Medicine and Geriatric wards of the REPOSI network,
- consent to participate to the study.
Exclusion Criteria:
- consent denial to participate to the study,
- absolute contraindication to OAC,
- re-hospitalisation for the subject already included in the study,
- life expectancy less than 6 months.
Sites / Locations
- Azienda Ospedaliera Universitaria Policlinico Sant'Orsola Malpighi
- Istituto Fondazione Poliambulanza
- Policlinico Universitario Mater Domini
- AO Universitaria Policlinico di Modena
- Azienda Ospedaliera S. Gerardo di Monza
- Ospedale degli Infermi
- Azienda Ospedaliera Universitaria - Ospedale Riuniti
- A.O. Ospedale di Circolo e Fondazione Macchi
- Azienda Consorziale Ospedaliera Policlinico
- Azienda Ospedaliera Papa Giovanni XXIII
- Azienda Ospedaliera Universitaria "Policlinico Vittorio Emanuele"
- Azienda Ospedaliera Universitaria San Martino - IST
- Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
- Azienda Ospedaliera di Padova
- Azienda Ospedaliera Universitaria Policlinico P. Giaccone
- Azienda SocioSanitaria Territoriale, Ospedale Civile "C.Mira" di Casorate Primo
- Policlinico San Matteo
- Ospedale San Giovanni Calibita Fatebenefratelli
- Policlinco Universitario Agostino Gemelli
- Ospedale SS Annunziata
Arms of the Study
Arm 1
Arm 2
Other
Other
Intervention
Control
Clinicians allocated to intervention arm will receive an e-learning educational program based on simulation-based technologies (Dr Sim). Dr Sim provides a powerful editing system that allows to create clinical cases according to the educational need and purposes. It will be distributed on an e-learning platform, allowing the user to act in a highly interactive learning environment. Management of the virtual patients is carried out interactively and each diagnostic and or therapeutic choice will be supported by any scientific data, guidelines recommendations, drug descriptions and literature references useful to address the best choice for that specific patient as it should be in real practice.
Clinicians allocated to control arm will not receive the e-learning educational program based on simulation-based technologies (Dr Sim).